Loading insider details...
Beta
Latest Form 4 (Jun 30, 2026): Grant/Award of 2,875 SCYX shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 30, 2026 | SCYNEXIS INC (SCYX) | Grant/Award | 2,875 | n/a |
| Jan 12, 2026 | Trevi Therapeutics, Inc. (TRVI) | Grant/Award | 375,000 | n/a |
| Jun 30, 2025 | SCYNEXIS INC (SCYX) | Grant/Award | 23,000 | n/a |
| Feb 19, 2025 | Arbutus Biopharma Corp (ABUS) | Grant/Award | 90,100 | n/a |
| Feb 5, 2025 | Arbutus Biopharma Corp (ABUS) | Sale | 22,183 | $72.8K |
| Jun 21, 2024 | SCYNEXIS INC (SCYX) | Grant/Award | 23,000 | n/a |
| Feb 6, 2024 | Arbutus Biopharma Corp (ABUS) | Grant/Award | 112,500 | n/a |
| Jun 23, 2023 | SCYNEXIS INC (SCYX) | Grant/Award | 10,000 | n/a |
| Jun 21, 2023 | SCYNEXIS INC (SCYX) | Grant/Award | 10,000 | n/a |
| Feb 3, 2023 | Arbutus Biopharma Corp (ABUS) | Grant/Award | 79,000 | n/a |